Pv12, a 6-Cys antigen of Plasmodium vivax, is localized to the merozoite rhoptry

Parasitology International

Volumn 61, Issue 3, 2012, Pages 443-449

  Li, Jian ^a,b   Ito, Daisuke ^c   Chen, Jun Hu ^a,e   Lu, Feng ^a,b   Cheng, Yang ^a   Wang, Bo ^a   Ha, Kwon Soo ^a   Cao, Jun ^b,d   Torii, Motomi ^d   Sattabongkot, Jetsumon ^f   Tsuboi, Takafumi ^c   Han, Eun Taek ^a  

^a Kangwon National University   (South Korea)

^b JIANGSU INSTITUTE OF PARASITIC DISEASES   (China)

^c EHIME UNIVERSITY   (Japan)

^d EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e INSTITUTE OF MATERIA MEDICA   (China)

^f MAHIDOL UNIVERSITY   (Thailand)

Author keywords

6 Cys domain; Cell free expression; Humoral immune response; Merozoite; Plasmodium vivax; Pv12; Rhoptry

Indexed keywords

CYSTEINE; POLYPEPTIDE; PV12 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGENICITY; ARTICLE; BIOINFORMATICS; CARBOXY TERMINAL SEQUENCE; CELL INVASION; CELL ORGANELLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISULFIDE BOND; ERYTHROCYTE; EXON; GENOME; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MEROZOITE; MOUSE; NONHUMAN; PARASITOSIS; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RHOPTRY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; BLOTTING, WESTERN; COMPUTATIONAL BIOLOGY; CYSTEINE; DNA, PROTOZOAN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ERYTHROCYTES; FLUORESCENT ANTIBODY TECHNIQUE; GENES, PROTOZOAN; HUMANS; MEROZOITES; MICE; MOLECULAR SEQUENCE DATA; PLASMODIUM VIVAX; PROTOZOAN PROTEINS; SEQUENCE ANALYSIS, DNA;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; POTATO VIRUS X;

EID: 84862778079     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2012.02.008     Document Type: Article

References (37)

1. Mendis K., Sina B.J., Marchesini P., Carter R. The neglected burden of Plasmodium vivax malaria. The American Journal of Tropical Medicine and Hygiene 2001, 64:97-106.
2. Price R.N., Tjitra E., Guerra C.A., Yeung S., White N.J., Anstey N.M. Vivax malaria: neglected and not benign. The American Journal of Tropical Medicine and Hygiene 2007, 77:79-87.
3. Price R.N., Douglas N.M., Anstey N.M. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Current Opinion in Infectious Diseases 2009, 22:430-435.
4. Patarroyo M.E., Patarroyo M.A. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines. Accounts of Chemical Research 2008, 41:377-386.
5. Romero P., Heimer E.P., Herrera S., Felix A.M., Nussenzweig R.S., Zavala F. Antigenic analysis of the repeat domain of the circumsporozoite protein of Plasmodium vivax. The Journal of Immunology 1987, 139:1679-1682.
6. Golenda C.F., Li J., Rosenberg R. Continuous in vitro propagation of the malaria parasite Plasmodium vivax. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:6786-6791.
7. Arevalo-Pinzon G., Curtidor H., Vanegas M., Vizcaino C., Patarroyo M.A., Patarroyo M.E. Conserved high activity binding peptides from the Plasmodium falciparum Pf34 rhoptry protein inhibit merozoites in vitro invasion of red blood cells. Peptides 2010, 31:1987-1994.
8. Gilson P.R., Nebl T., Vukcevic D., Moritz R.L., Sargeant T., Speed T.P., et al. Identification and stoichiometry of glycosylphosphatidylinositol-anchored membrane proteins of the human malaria parasite Plasmodium falciparum. Molecular & Cellular Proteomics 2006, 5:1286-1299.
9. Wang L., Mohandas N., Thomas A., Coppel R..L Detection of detergent-resistant membranes in asexual blood-stage parasites of Plasmodium falciparum. Molecular and Biochemical Parasitology 2003, 130:149-153.
10. Sanders P.R., Gilson P.R., Cantin G.T., Greenbaum D.C., Nebl T., et al. Distinct protein classes including novel merozoite surface antigens in raft-like membranes of Plasmodium falciparum. The Journal of Biological Chemistry 2005, 280:40169-40176.
11. Kooij T.W., Janse C.J., Waters A.P. Plasmodium post-genomics: better the bug you know?. Nature Reviews Microbiology 2006, 4:344-357.
12. Carlton J.M., Adams J.H., Silva J.C., Bidwell S.L., Lorenzi H., Caler E., et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 2008, 455:757-763.
13. Perezleal O., Sierra A.Y., Barrero C.A., Moncada C., Martinez P., Cortes J., et al. Plasmodium vivax merozoite surface protein 8 cloning, expression, and characterisation. Biochemical and Biophysical Research Communications 2004, 324:1393-1399.
14. Valderrama-Aguirre A., Quintero G., Gomez A., Castellanos A., Perez Y., Mendez F., et al. Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit. The American Journal of Tropical Medicine and Hygiene 2005, 73:16-24.
15. Martinez P., Suarez C., Gomez A., Cardenas P., Guerrero J., Patarroyo M. High level of conservation in Plasmodium vivax merozoite surface protein 4 (PvMSP4). Infection, Genetics and Evolution 2005, 5:354-361.
16. Mongui A., Angel D., Guzman C., Vanegas M., Patarroyo M. Characterisation of the Plasmodium vivax Pv38 antigen. Biochemical and Biophysical Research Communications 2008, 376:326-330.
17. Mongui A., Angel D.I., Gallego G., Reyes C., Martinez P., Guhl F., et al. Characterization and antigenicity of the promising vaccine candidate Plasmodium vivax 34kDa rhoptry antigen (Pv34). Vaccine 2009, 28:415-421.
18. Putaporntip C., Udomsangpetch R., Pattanawong U., Cui L., Jongwutiwes S. Genetic diversity of the Plasmodium vivax merozoite surface protein-5 locus from diverse geographic origins. Gene 2010, 456:24-35.
19. Garzón-Ospina D., Romero-Murillo L., Tobón L.F., Patarroyo M.A. Low genetic polymorphism of merozoite surface proteins 7 and 10 in Colombian Plasmodium vivax isolates. Infection, Genetics and Evolution 2011, 11:528-531.
20. Gerloff D.L., Creasey A., Maslau S., Carter R. Structural models for the protein family characterized by gamete surface protein Pfs230 of Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:13598-13603.
21. García J., Curtidor H., Pinzón C.G., Vanegas M., Moreno A., Patarroyo M.E. Identification of conserved erythrocyte binding regions in members of the Plasmodium falciparum Cys6 lipid raft-associated protein family. Vaccine 2009, 27:3953-3962.
22. Carter R., Coulson A., Bhatti S., Taylor B.J., Elliott J.F. Predicted disulfide-bonded structures for three uniquely related proteins of Plasmodium falciparum, Pfs230, Pfs48/45 and Pf12. Molecular and Biochemical Parasitology 1995, 71:203-210.
23. Angel D.I., Mongui A., Ardila J., Vanegas M., Patarroyo M.A. The Plasmodium vivax Pv41 surface protein: identification and characterization. Biochemical and Biophysical Research Communications 2008, 377:1113-1117.
24. Chen J.H., Jung J.W., Wang Y., Ha K.S., Lu F., Lim C.S., et al. Immunoproteomics profiling of blood stage Plasmodium vivax infection by high-throughput screening assays. Journal of Proteome Research 2010, 9:6479-6489.
25. Bozdech Z., Mok S., Hu G., Imwong M., Jaidee A., Russell B., et al. The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:16290-16295.
26. Jagannadham M.V., Abou-Eladab E.F., Kulkarni H.M. Identification of outer membrane proteins from an Antarctic bacterium Pseudomonas syringae Lz4W. Molecular & Cellular Proteomics 2011, 10. [M110 004549].
27. Schultz J., Milpetz F., Bork P., Ponting C.P. SMART, a simple modular architecture research tool: identification of signaling domains. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:5857-5864.
28. Letunic I., Doerks T., Bork P. SMART 6: recent updates and new developments. Nucleic Acids Research 2009, 37:D229-D232.
29. Sunyaev S.R., Eisenhaber F., Rodchenkov I.V., Eisenhaber B., Tumanyan V.G., Kuznetsov E.N. PSIC: profile extraction from sequence alignments with position-specific counts of independent observations. Protein Engineering 1999, 12:387-394.
30. Tsuboi T., Takeo S., Iriko H., Jin L., Tsuchimochi M., Matsuda S., et al. Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infection and Immunity 2008, 76:1702-1708.
31. Tsuboi T., Takeo S., Sawasaki T., Torii M., Endo Y. An efficient approach to the production of vaccines against the malaria parasite. Methods in Molecular Biology 2010, 607:73-83.
32. Ihalamulla R.L., Mendis K.N. Plasmodium vivax: isolation of mature asexual stages and gametocytes from infected human blood by colloidal silica (Percoll) gradient centrifugation. Transactions of the Royal Society of Tropical Medicine and Hygiene 1987, 81:25-28.
33. Neeley E.S., Kornblau S.M., Coombes K.R., Baggerly K.A. Variable slope normalization of reverse phase protein arrays. Bioinformatics 2009, 25:1384-1389.
34. Chen J.H., Wang Y., Ha K.S., Lu F., Suh I.B., Lim C.S., et al. Measurement of naturally acquired humoral immune responses against the C-terminal region of the Plasmodium vivax MSP1 protein using protein arrays. Parasitology Research 2011, 109:1259-1266.
35. Besteiro S., Dubremetz J.F., Lebrun M. The moving junction of apicomplexan parasites: a key structure for invasion. Cellular Microbiology 2011, 13:797-805.
36. Arevalo-Pinzon G., Curtidor H., Patino L.C., Patarroyo M.A. PvRON2, a new Plasmodium vivax rhoptry neck antigen. Malaria Journal 2011, 10:60.
37. Cao J., Kaneko O., Thongkukiatkul A., Tachibana M., Otsuki H., Gao Q., et al. Rhoptry neck protein RON2 forms a complex with microneme protein AMA1 in Plasmodium falciparum merozoites. Parasitology International 2009, 58:29-35.